Effect of Caffeine on Ocular Circulation in High Myopes
1 other identifier
interventional
18
1 country
1
Brief Summary
To investigate the effect of caffeine on ocular circulation by using Optical Coherence Tomography and Optical Coherence Tomography Angiography. This study will evaluate blood supply to the inner and outer retina after consumption of 200mg caffeine capsule, in particular its effect in high myopes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2017
CompletedFirst Submitted
Initial submission to the registry
September 20, 2017
CompletedFirst Posted
Study publicly available on registry
September 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedJuly 29, 2020
July 1, 2020
2.3 years
September 20, 2017
July 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Choroidal thickness
Choroidal thickness measured by the optical coherence tomography
Within 4 hours
Secondary Outcomes (1)
Retinal vessel density
Within 4 hours
Study Arms (2)
Caffeine
ACTIVE COMPARATORTo determine the effect of caffeine on ocular circulation in high myopes by consuming 200 mg caffeine capsule
Vitamin E
PLACEBO COMPARATORTo determine the effect of caffeine on ocular circulation in high myopes by consuming and 200 International Unit vitamin E control capsule, as control
Interventions
Eligibility Criteria
You may qualify if:
- Refractive error should be at least -6 Diopters or lower (spherical equivalent)
- Best corrected visual acuity of at least 6/6
- Non-smoker
You may not qualify if:
- \- Diagnosed with any ocular diseases and systemic diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of optometry
Hong Kong, Hong Kong
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kwok Cheung Andrew Lam, PhD
The Hong Kong Polytechinc University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will not see the label of the capsule.
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 20, 2017
First Posted
September 27, 2017
Study Start
September 1, 2017
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
July 29, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share